Loading…
Opening company profile
Loading company metrics, contact preview, and tender history.
Public records across all portals
No organisation data
Try another outcome or period.
No state data
Try another outcome or period.
Gene Synthesis, cloning and expression quality check of proteins
Phase-I Development of antisera in mice (5-6 mice/antigen), Phase-II Hybridoma generation via cell fusion and subsequent screening for monoclonal antibody produ, Phase-III Sub- cloning, screening and isotyping of three distinct clones specific to each antigen (0, Phase-IV Large scale productin and purification of monoclonal antibodies from the confirmed positive
Gene Synthesis, cloning and expression quality check of proteins
Phase-I Development of antisera in mice (5-6 mice/antigen), Phase-II Hybridoma generation via cell fusion and subsequent screening for monoclonal antibody produ, Phase-III Sub- cloning, screening and isotyping of three distinct clones specific to each antigen (0, Phase-IV Large scale productin and purification of monoclonal antibodies from the confirmed positive
2 more tenders are hidden. Create a free account to unlock the full tender history, filters, and exports.
This profile is built from what portals disclose publicly. Since several states never release bidder lists or quoted prices, it likely understates the company’s true footprint. A tender is counted as won when the company either received the award or stood L1 at financial bid opening, even if the formal award is still pending. TenderKart compiles these public records independently and has no association with any government portal, buyer, or bidder.